Lung Cancer Study Uncovers Mutation in a Cell-Signaling Pathway

Researchers have uncovered mutations in a cell-signaling pathway that plays a role in forming tumors, studying the most common type of lung cancer. The new knowledge may expand treatments for patients because drugs targeting some of these genetic changes already are available or are in clinical trials. Reporting July 9 in iNature/i, investigators from The Cancer Genome Atlas (TCGA), including researchers at Washington University School of Medicine in St. Louis, Harvard Medical School ...